A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
National Cancer Institute (NCI)
Center for International Blood and Marrow Transplant Research
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Takeda
National Institutes of Health Clinical Center (CC)
Disc Medicine, Inc
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Zhejiang Cancer Hospital
The First Hospital of Jilin University
Ossium Health, Inc.
Mayo Clinic
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Institute of Hematology & Blood Diseases Hospital, China
Centre Hospitalier Universitaire de Nice
Memorial Sloan Kettering Cancer Center
Center for International Blood and Marrow Transplant Research
St. Jude Children's Research Hospital
University of Vermont
Apollo Therapeutics Ltd
First Affiliated Hospital of Zhejiang University
National Institutes of Health Clinical Center (CC)
Institut Pasteur du Cambodge
Qilu Pharmaceutical Co., Ltd.
Ohio State University Comprehensive Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
Infanta Leonor University Hospital
Grit Biotechnology
Medical University of Gdansk
Ohio State University Comprehensive Cancer Center